Soria Jiménez, Luis (Date of defense: 2023-02-17)
Although the dual anti-HER2 blockade with trastuzumab and pertuzumab monoclonal antibodies has improved the outcome of patients with HER2+ breast cancer, a significant number of patients relapse. ...
Factor derivado del estroma 1 (SDF-1) (1)